1. Home >
  2. M&A >
  3. Buyout (LBO, MBO, MBI) >
  4. United States >
  5. Florida >
  6. ArchiMed Acquires Arkstone

Buyout (LBO, MBO, MBI) • Life Science

ArchiMed Acquires Arkstone

On July 30, 2025, private equity firm ArchiMed acquired life science company Arkstone

Acquisition Context
  • This is ArchiMed’s 14th transaction in the Life Science sector.
  • This is ArchiMed’s 11th transaction in the United States.
  • This is ArchiMed’s 2nd transaction in Florida.

Explore All 461 Buyout (LBO, MBO, MBI) Life Science Deals - Search the Database Free


M&A Deal Summary
Date July 30, 2025
Target Arkstone
Sector Life Science
Buyer(s) ArchiMed
Deal Type Buyout (LBO, MBO, MBI)

Target Company

Arkstone

Boca Raton, Florida, United States
Arkstone is a biotechnology company providing clinical decision support powered by ML and AI, helping healthcare providers optimize antimicrobial use. Its OneChoice Report empowers clinicians to prescribe with precision and confidence, fighting antimicrobial resistance and democratizing infectious disease expertise. Arkstone is based in Boca Raton, Florida.
Explore More Deals

Browse All 215,262 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

ArchiMed

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2014
PE ASSETS 8.0B EUR
Size Mega
Type Sector Focused
DESCRIPTION

ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €10 million to €1 billion per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.

Deal Context for Buyer #
Overall 38 of 38
Sector: Life Science 14 of 14
Type: Buyout (LBO, MBO, MBI) 21 of 21
State: Florida 2 of 2
Country: United States 11 of 11
Year: 2025 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-07-21 ZimVie

Westminster, Colorado, United States

ZimVie is a medical technology company, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. ZimVie is based in Westminster, Colorado.

Buy $730M

Explore Related M&A Activity

Life Science M&A - Buyout (LBO, MBO, MBI) M&A Deals - Florida M&A - United States M&A - 2025 M&A

Mergr

Solution for

Product

Company

Legal